ArticleJournal of cancer research and clinical oncology2022

Aberrant MEK5 signalling promotes clear cell renal cell carcinoma development via mTOR activation.

Fangzhou Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.